4 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Malignant Lymphomas: new trials by email Literature Review of Malignant Lymphomas trials Research Report on Malignant Lymphomas
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas Gemcitabine HCl Oral Formulation - Advanced Solid Malignancies, Malignant Lymphomas | Phase 1 | Completed | InnoPharmax Inc. | 37 | 2013-04-01 | 2019-07-08 |
| Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology Chemotherapy-induced Symptomatic Anaemia, Solid Tumours | Completed | Hospira, now a wholly owned subsidiary of Pfizer | 291 | 2010-12-01 | 2017-03-20 | |
| Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor Allogeneic NK cells - Malignant Lymphomas, Solid Tumors | Phase 1 | Completed | Seoul National University Hospital | 18 | 2010-09-01 | 2013-08-19 |
| Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies 4SC-205 - Advanced and Incurable Solid Tumors, Malignant Lymphomas | Phase 1 | Completed | 4SC AG | 60 | 2010-01-01 | 2015-04-13 |
Lymphoma (4) · Multiple Myeloma (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1) · Vascular Diseases (1)
4SC AG (1) · Hospira, now a wholly owned subsidiary of Pfizer (1) · InnoPharmax Inc. (1) · Seoul National University Hospital (1)
Germany (2) · South Korea (1) · Taiwan (1)
Chia-Chi Lin, MD (1) · Klaus Mross, PD Dr. med. (1) · Wu-Chou Su, MD (1) · Yee Chao, MD (1)